Tengion names Flora to board of directors

Wednesday, September 28, 2011

Tengion has named Scott Flora to its board of directors. Flora brings to Tengion more than 20 years of experience building and managing successful wound healing and surgical device businesses.  He most recently served as global business unit president of surgical devices at Covidien.

[Read More]

Tengion CEO Nichtberger resigns

Friday, July 1, 2011

Dr. Steven A. Nichtberger has resigned as president and CEO of Tengion, a regenerative medicine company focused on developing replacement organs and tissues grown from a person’s own cells, according to a report in the Philadelphia Business Journal.

[Read More]

Tengion adds renal experts to R&D advisory panel

Tuesday, March 29, 2011

Tengion, a company involved in regenerative medicine, announced the addition of two renal research and clinical experts, Ben Humphreys, M.D., Ph.D., from the Harvard Stem Cell Institute and Giuseppe Remuzzi, M.D., F.R.C.P., from the Mario Negri Institute, to its panel of R&D advisors.

[Read More]